Search

Objective: Digital mental health interventions (DMHIs) are typically designed as "one-size fits all" which may perpetuate health disparities for racialized minorities. This systematic review identified culturally adapted DMHIs and examined their efficacy and acceptability among racial and ethnic minorities. Method: PsycINFO, Web of Science, and Pubmed databases were searched between 2000 and 2021. Studies that examined the development or impact of a culturally adapted DMHI for racial or ethnic minority populations using quantitative and/or qualitative methodologies were included. Meta-analyses explored the efficacy of DMHIs, and moderator analyses were used to identify differences in effect sizes due to study quality, clinical outcomes, therapist support, and attrition. Results: Thirty-two studies met inclusion criteria and were reviewed. DMHIs were deemed acceptable and feasible in most studies (n = 24). Among eligible randomized controlled studies (n = 12) comprising 653 participants, results indicated that culturally adapted DMHIs produced a large, positive, significant effect (g = 0.90) across a range of outcomes when compared to wait-list and treatment as usual control conditions. The average attrition rate per study was 42%, and most participants did not complete all modules despite reporting high satisfaction. Conclusions: Culturally adapted DMHIs are efficacious and acceptable. Such interventions represent a powerful opportunity to circumvent barriers to mental health treatment and improve mental health equity among racially and ethnically minoritized communities. However, the prevalence of feasibility studies, lack of active comparison treatments—and limited research for Black and Indigenous populations—indicate that more research is needed to achieve this purpose. Recommendations are discussed. What is the public health significance of this article?: This study provides strong evidence that culturally adapted digital mental health interventions are effective for racial and ethnic minority communities, who report high satisfaction after using them. Further research is needed to examine the utility of these interventions among Black and Indigenous populations and to improve intervention adherence. [ABSTRACT FROM AUTHOR]

Objective: This is the first randomized trial comparing virtual reality exposure therapy to in vivo exposure for social anxiety disorder. Method: Participants with a principal diagnosis of social anxiety disorder who identified public speaking as their primary fear (N = 97) were recruited from the community, resulting in an ethnically diverse sample (M age = 39 years) of mostly women (62%). Participants were randomly assigned to and completed 8 sessions of manualized virtual reality exposure therapy, exposure group therapy, or wait list. Standardized self-report measures were collected at pretreatment, posttreatment, and 12-month follow-up, and process measures were collected during treatment. A standardized speech task was delivered at pre- and posttreatment, and diagnostic status was reassessed at 3-month follow-up. Results: Analysis of covariance showed that, relative to wait list, people completing either active treatment significantly improved on all but one measure (length of speech for exposure group therapy and self-reported fear of negative evaluation for virtual reality exposure therapy). At 12-month follow-up, people showed significant improvement from pretreatment on all measures. There were no differences between the active treatments on any process or outcome measure at any time, nor differences on achieving partial or full remission. Conclusion: Virtual reality exposure therapy is effective for treating social fears, and improvement is maintained for 1 year. Virtual reality exposure therapy is equally effective as exposure group therapy; further research with a larger sample is needed, however, to better control and statistically test differences between the treatments. [ABSTRACT FROM AUTHOR]

Reports the 12-month follow-up of virtual reality and standard exposure therapies of patients with the fear of flying. Superiority of virtual reality exposure (VRE) therapy and standard exposure (SE) to wait-list control; Maintenance of patient of their treatment gains; Percentage of VRE and SE participants flown on real airplane.